Is Organigram Finally a Buy?

: OGI | OrganiGram Holdings Inc. News, Ratings, and Charts

OGI – OrganiGram (OGI) is reducing staff. Is it time to buy.

Last week OrganiGram (OGI) announced that it would be reducing staff by 25% as the COVID-19 pandemic weighs on the industry. The decision to cut staffing will affect approximately 220 employees, including a small number of employees not on temporary layoff. 

The company also plans to move forward with 433 active employees who operate out of its indoor production facility in Moncton, New Brunswick. OGI has a total workforce of 609 employees, including 84 employees who remain on temporary layoff, but may be called back to work.

With its reduced workforce, the company believes that it can continue to meet current and anticipated near-term demand levels.

OrganiGram’s CEO Greg Engel said, “These decisions are never easy to make, but we are committed to ensuring the Company is appropriately sized relative to market conditions – we are incredibly grateful for the commitment that our affected employees have made in helping build the Company that Organigram is today.”

I view the reduction in staff as positive for the company as it adjusts to the current market environment,  I remain optimistic in the long-term for many reasons

First, the company has a healthy balance sheet compared to some of its peers. OGI has very little debt, a strong cash position, and fewer operating expenses than some of its larger competitors with huge facilities. Furthermore, the company will be focusing on 2.0 products with a new production line capable of producing 4 million kgs of edible chocolate per year.

Though layoffs are never pleasant, it is prudent for the company to reduce its size and become leaner and more efficient as the economy faces major headwinds due to the spread of the coronavirus. 


OGI shares were trading at $1.61 per share on Tuesday afternoon, up $0.05 (+3.21%). Year-to-date, OGI has declined -34.29%, versus a -1.04% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
OGIGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Does Trump Change Stock Market Outlook?

The rally of the S&P 500 (SPY) after the election gives a sense that investors are happy that Trump was elected. But perhaps there is more to this story than meets the eye. That’s why Steve Reitmeister shares his updated market outlook taking into account the pros and cons of Trumps proposed new policies. This comes with a preview of his top 11 stocks to buy now.

3 Streaming Stocks Benefiting from Cord-Cutting Trends

As streaming continues to dominate the digital entertainment landscape, the global streaming market presents a lucrative investment opportunity. So, it could be ideal to invest in fundamentally solid streaming stocks Netflix (NFLX), Walt Disney (DIS), and Roku (ROKU). Read further...

3 Gold Stocks to Buy as Safe-Haven Demand Grows

Gold is a stable investment now due to its role as a safe-haven asset during economic uncertainty, rising demand, industrial use, and growth, bolstered by central bank purchases and interest rate cuts. Therefore, investors should consider investing in top gold stocks such as Newmont (NEM), Barrick Gold (GOLD), and Agnico Eagle Mines (AEM). Read more...

3 AI Stocks Transforming Industries and Driving Future Growth

With rapid digitalization, rapid adoption, and development, as well as surging demand, the AI market is on the rise. Amid this backdrop, investors could buy fundamentally solid AI stocks NVIDIA Corporation (NVDA), Microsoft (MSFT), and Meta Platforms (META) poised for substantial gains. Continue reading...

Updated Stock Market Expectations

The S&P 500 (SPY) has already reached an impressive goal of hitting 6,000. Yet you can see how much shares are struggling now up against this resistance. Steve Reitmeister shares his views on what comes next for the market and his top 10 stocks to stay on the right side of the action.

Read More Stories

More OrganiGram Holdings Inc. (OGI) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All OGI News